Phase

n/a (3,746)

phase 2 (1,888)

phase 3 (1,076)

phase 4 (949)

phase 1 (854)

phase 1/phase 2 (334)

phase 2/phase 3 (151)

early phase 1 (116)

Funder Type

Other (7,600)

Industry (2,709)

NIH (1,526)

U.S. Fed (109)

Study Type

Interventional (9,115)

Observational (2,454)

Observational [Patient Registry] (232)

Expanded Access (143)

dual eligible

Showing 1 - 25 of >10,000

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

ST Elevation Myocardial Infarction Trial in Geneva (Successful primary PCI, defined as primary PCI of the culprit lesion with =1

Not yet recruiting

ST Elevation Myocardial Infarction

Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation

Geneva, Switzerland

Geneva University Hospitals

Mar 25, 2023

Dual-layer Micromesh Stent in Elective Treatment of Carotid

Active, not recruiting

Carotid Artery Stenosis

Roadsaver

Aalst, Belgium
+56 more

Dec 9, 2021

Early On-treatment Transcriptional Profiling as Predictor of

Recruiting

HER2-positive Breast Cancer
+2 more

Trastuzumab (neoadjuvant)
+2 more

Hospitalet de Llobregat, Barcelona, Spain

Institut Català d'Oncologia l'Hospitalet

Jun 12, 2023

Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual

Recruiting

Coronary Artery Disease
+6 more

De-escalated Dual Antiplatelet Therapy
Dual Antiplatelet Therapy

Beijing, China

Fuwai Hospital

Dec 13, 2022

Alzheimer Trial in Izmir (Dual-Task Training, Control Group)

Not yet recruiting

Alzheimer Disease

Dual-Task Training
Control Group

İzmir, Karsıyaka, Turkey

Karsiyaka Municipality Day Living Center

Mar 1, 2023

Femur Fracture Trial in Rochester (Single Distal Femur Implant, Dual Distal Femur Implant)

Not yet recruiting

Femur Fracture

Single Distal Femur Implant
Dual Distal Femur Implant

Rochester, Minnesota

Mayo Clinic Minnesota

Sep 2, 2023

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation

GEP-NET
+3 more

Copenhagen, Denmark

Rigshospitalet

Jan 24, 2023

Huaier Granules in Postoperative Adjuvant Therapy for Non-small

Not yet recruiting

Non-small Cell Lung Cancer

Huaier granule
Control

Shenyang, Liaoning, China

Liaoning Cancer Hospital & Institute

Oct 27, 2023

Diagnostic Accuracy of Dual-energy CT

Completed

Osteoarthritis
+6 more

CT-scanning

Copenhagen, DK, Denmark

The Parker Institute, Bispebjerg and Frederiksberg Hospital

Oct 21, 2022

Helicobacter Pylori Infection Trial in Israel, United States (Dual Mode BreathID Hp System)

Completed

Has Results

Helicobacter Pylori Infection

Dual Mode BreathID Hp System

Tucson, Arizona
+12 more

Dec 19, 2022

Healthy Subjects Trial in Groningen (Apraglutide)

Recruiting

Healthy Subjects

Apraglutide

Groningen, Netherlands

ICON Clinical Research Unit

Aug 15, 2023

Dislocation, Hip Trial in United States (Dual mobility implant, Traditional, Single-bearing hip implant)

Recruiting

Dislocation, Hip

Dual mobility implant
Traditional, Single-bearing hip implant

Los Angeles, California
+3 more

Oct 27, 2022

19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

Recruiting

19 and 22+ B Cell Hematologic Tumors
19 and 20+ B Cell Hematologic Tumors

Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells

Wuhan, Hubei, China

Tongji Hospital

Jan 11, 2023

Acute Hypercapnic Respiratory Failure, Acute Hypoxemic Respiratory Failure Trial (Investigational full-face mask with expiratory

Not yet recruiting

Acute Hypercapnic Respiratory Failure
Acute Hypoxemic Respiratory Failure

Investigational full-face mask with expiratory washout
+2 more

(no location specified)

Aug 21, 2023

Smoking, Smoking, Cigarette, E-Cig Use Trial (very low nicotine content cigarettes, normal nicotine content cigarettes, Study

Not yet recruiting

Smoking
+3 more

very low nicotine content cigarettes
+2 more

(no location specified)

Jul 22, 2022

Smoking Cessation, Electronic Cigarette Use, Cigarette Smoking Trial in Charleston (Regular Nicotine patch and lozenge dose,

Not yet recruiting

Smoking Cessation
+2 more

Regular Nicotine patch and lozenge dose
Augmented Nicotine patch and lozenge dose

Charleston, South Carolina

Medical University of South Carolina - Charleston

Oct 19, 2023

Severe Aortic Stenosis Trial in Seoul (Aspirin single antiplatelet therapy, Clopidogrel single antiplatelet therapy)

Not yet recruiting

Severe Aortic Stenosis

Aspirin single antiplatelet therapy
Clopidogrel single antiplatelet therapy

Seoul, Korea, Republic of

Yonsei University Health System, Severance Hospital

Aug 8, 2022

Bleeding and Ischemic Risk

Completed

Coronary Artery Disease
Percutaneous Coronary Intervention

Percutaneous coronary intervention

New York, New York

Icahn School of Medicine at Mount Sinai

Oct 13, 2023

(DIVA) in Medium-vessel-occlusion Strokes: a Retrospective Study

Not yet recruiting

Acute Ischemic Stroke Due to Medium-vessel-occlusion

alteplase
Alteplase + possible complementary IVT with tenecteplase

Corbeil-Essonnes, France

Centre Hospitalier Sud Francilien

Apr 13, 2023

Disparities in Proportion of Ticagrelor and Prasugrel-eligible

Not yet recruiting

Acute Myocardial Infarction

There was no intervention necessary.

Heidelberg, Baden-Württemberg, Germany

University Hospital of Heidelberg

Mar 19, 2023

Type 1 Diabetes Trial in Valencia (Automated insulin delivery system algorithm with a dual-hormone configuration (insulin and

Not yet recruiting

Type 1 Diabetes

Automated insulin delivery system algorithm with a dual-hormone configuration (insulin and glucagon) for glucose control
Automated insulin delivery system with a single-hormone configuration (insulin) with rescue carbohydrate recommendations for glucose control